PubMed Health⌕ Search

Biomedical subjects

G Forster

Publications and source records attributed to G Forster.

At least 55 records · Page 3Linked to original sources
PubMed1990

Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum.

We measured tumour cellular DNA in 102 patients entered into two phase III trials of chemotherapy for end stage squamous carcinoma of the head and neck. The median survival of untreated patients with aneuploid tumours was 55 days compared with 224 days for patients treated with cisplatinum. This difference was highly significant. In contrast the median survival of untreated patients with diploid tumours was 74 days compared with 118 days for treated patients. Although this difference is statistically significant, the increased survival of 6 weeks is of no clinical benefit compared with the prolongation of survival of 6 months in patients with aneuploid tumours. Multivariate analysis showed that the significant predictors of survival were Karnofsky status, response to chemotherapy and ploidy.

Aged↗
PubMed1990

Synthesis and resolution of the novel appetite suppressant 2-benzylmorpholine, a nonstimulant isomer of phenmetrazine.

The synthesis of 2-benzylmorpholine from allylbenzene together with its resolution into its (+)- and (-)-enantiomers is reported. Oral dosing of the racemate to dogs caused appetite suppression with an ED50 of 3 and 5.5 mg kg-1 at 1 and 2 h, respectively, after access to a meat meal. No stimulant activity was observed in dogs given oral doses of 200 mg kg-1 but the appetite suppressant effect in dogs declined during 20 days of chronic oral dosing at 10 mg kg-1. Appetite suppression activity was shown to reside in the (+)-enantiomer.

Administration, Oral↗
PubMed1989

Prognostic value of nucleolar organizer regions and ploidy values in advanced colorectal cancer.

The prognostic value of nucleolar organizer regions and ploidy status in patients with Dukes' C colorectal cancer was determined. In addition, nucleolar organizer regions and ploidy status were compared with the established prognostic indices age, sex, tumour location and degree of histological differentiation. Fifty-one patients (27 men, 24 women) aged 35-81 years (median 64.8 years) were studied. Five years after presentation, 16 patients were alive and well. Survivors had significantly lower nucleolar organizer region counts (median value and range) in primary tumours 12 (8-15) and lymph node metastases 11 (8-15) than non-survivors 17 (14-25) and 18 (13-25) respectively (P less than 0.05). Fewer survivors had aneuploid tumours than non-survivors: four survivors compared with 17 non-survivors. In a regression analysis model, nucleolar organizer regions were the most important individual variable for predicting survival (chi2 = 15, P less than 0.01) while ploidy values (chi2 = 6, P less than 0.2) were equivalent to histological differentiation.

Adult↗
PubMed1989

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

In a randomised controlled trial recombinant interferon alpha 2A (Roferon-A, rIFN alfa A) given at a dosage of 10 million units (MU)/m2 thrice weekly for six months was significantly better (p less than 0.02) than no treatment in producing a sustained loss of hepatitis Be antigen (HBeAg) in hepatitis B virus (HBV) chronic carriers. Although lower doses (5 MU/m2 and 2.5 MU/m2) also produced some responses, the seroconversion rate was not significantly greater than that observed in the control group. Sixteen of the 45 patients receiving interferon were human immunodeficiency virus (HIV) antibody positive: none of these responded. Forty one per cent of the anti-HIV negative patients receiving interferon (12/29, p less than 0.005) lost HBeAg and 17% (5/29) lost hepatitis B surface antigen (HBsAg). The response rate among these anti-HIV negative patients receiving at least three months therapy was 46% and 19% respectively. Low pretreatment HBV-DNA and absence of anti-HIV were the only significant independent variables predicting response to therapy (p less than 0.03 and p less than 0.05 respectively). In six patients, neutralising antibodies to alpha interferon were detected during therapy, the majority being non-responders.

Adult↗
PubMed1988

AIDS and HIV infection.

Explore the source record for details and available documents.

Acquired Immunodeficiency Syndrome↗
PubMed1986

(S)-3-[(benzyloxy)methyl]morpholine hydrochloride: a nonstimulant appetite suppressant without conventional neurotransmitter releasing properties.

The synthesis and appetite-suppressant activity of (S)-3-[(benzyloxy)methyl]morpholine hydrochloride in dogs are reported. The oral ED50 for appetite suppression in dogs of 3 was 12 mg/kg, and it was tolerated up to 200 mg/kg. 3 had no inhibitory effect on the release or uptake of noradrenaline, dopamine, or serotonin at 10(-5) M. The (R) enantiomer of 3 was not anorexiant.

Animals↗
PubMed1976

[The feigned release of cell enzymes. Distribution and transport of cell enzymes within the extracellular space. I (author's transl)].

A sudden increase of enzyme activities in plasma is not necessarily due to a release of enzymes from damaged cells. Three experimental models were used to demonstrate that acute alterations of enzyme activities, as much as +/- 15%, can be caused by fluid-shifts between the intra- and extravascular compartments. Venous occlusion of the forearm by tourniquet produces an increase of the intravascular hydrostatic pressure and subsequently results in a decrease of the plasma volume distal to the tourniquet. Because enzyme molecules are not freely diffusible across the capillary membrane the enzymatic activity increases proportionally to the decrease of plasma volume. Changes in the body posture are accompanied by changes in plasma volume and similarly by alterations in the concentration of plasma-proteins and by alterations in intravascular enzyme activities. Increased enzyme activities in plasma during strenuous physical effort are due chiefly to a concentration of macromolecules within the intravascular space because of a decrease in plasma volume and not to a release of enzymes from hypoxic muscle cells. During recovery after termination of the exercise there is a second and longer lasting increase in enzyme activities in plasma which could be related to a release of enzymes from injured cells. It is suggested that some of these changes could be due to an increase in lymph flow and thereby an increasing transport of enzymes from the interstitial to the intravascular compartment.

Biological Transport↗
PubMed1975

Aseptic meningitis as a complication of scinticysternography utilizing 111Indium-dtpa.

The intrathecal administration of numerous substances has been known to cause arachnoiditic as well as aseptic meningitic reactions. Pleocytosis and increased protein in the CSF are well known findings following administration of air or myelographic dyes. This has also been observed with antibiotics. Even intrathecal steroids (e.g. depo-medrol) have been implicated in aseptic meningitic reactions. Despite the wide variety of causative agents, only a small percentage of patients develop clinical manifestations of aseptic meningitis. Are these reactions then caused by specific auto-immune type responses, or are they directly related to local irritants in each case, or a combination of both factors?

Female↗